Journal of veterinary emergency and critical care
-
J Vet Emerg Crit Care (San Antonio) · Mar 2021
ReviewThe role of cryoprecipitate in human and canine transfusion medicine.
To evaluate the current role of cryoprecipitate in human and canine transfusion medicine. ⋯ In the United States, cryoprecipitate remains the standard of care for fibrinogen replenishment in the bleeding human trauma patient. Its preferential selection for this purpose is the subject of several ongoing human clinical trials. Timely incorporation of cryoprecipitate into the transfusion protocol of the individual bleeding patient with hypofibrinogenemia may conserve blood products, mitigate adverse transfusion-related events, and improve patient outcomes. Cryoprecipitate is readily available, effective, and safe for use in dogs. The role of this blood product in clinical canine patients with acquired coagulopathy remains unknown.